|
|
Article: Research from Centre Hospitalier Lyon Sud in follicular lymphoma provides new insights.
- Article from:
- Blood Weekly
- Article date:
- September 4, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to recent research from Pierre-Benite, France, " The treatment of patients with follicular lymphoma has changed with the introduction of high-dose therapy (HDT) with autologous stem-cell transplant then with rituximab. The effect of these two strategies on the outcome of relapsing patients with follicular lymphoma has never been compared."
"Patients and Methods We analyzed two cohorts of patients treated in two successive randomized studies with the same treatment, cyclophosphamide, doxorubicin, teniposide, and prednisolone plus interferon, to evaluate the role of rituximab and HDT in salvage therapy after first disease progression or relapse. Of the ...
Related newspaper, magazine, and journal articles:
|
|
Article: Advanced follicular lymphoma responds to ...
Clinical Oncology Week;
February 2, 2004 ;
700+ words
... ... patients with follicular lymphoma treated with an ... with advanced follicular lymphoma," the researchers ... the treatment of follicular lymphoma: Retrospective ... was prepared by Clinical Oncology Week editors from ...
|
|